| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |